CASE Blog – Unveiling Healthcare Giants’ Impact on Consumers
The House Budget Committee’s recent hearing, “Breaking Up Health Care Monopolies: Examining the Budgetary Effects of Health Care Consolidation,” brought...
The House Budget Committee’s recent hearing, “Breaking Up Health Care Monopolies: Examining the Budgetary Effects of Health Care Consolidation,” brought...
For decades, politicians like Vermont Senator Bernie Sanders have been calling for a national takeover of healthcare. Though this...
Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement in response to President...
Alexandria, Virginia — This week CASE filed comments in response to an inter-agency request by the federal government to...
January 3, 2024 Every holiday season marks a time when people are swept up in the spirit of giving....
December 8, 2023 This week, the Biden administration announced plans to drastically expand the use of Bayh-Dole Act “march-in”...
October 4, 2023 President Biden announced yesterday that the makers of the first 10 drugs selected for so-called Medicare...
September 13, 2023 (Alexandria, Virginia) — Today Consumer Action for a Strong Economy (CASE), urged the House Committee on...
September 1, 2023 The rise of pharmacy benefit managers (PBMs) has transformed them into the dominant force in U.S....
August 29, 2023 Today, the Centers for Medicare & Medicaid Services (CMS) released their list of the first 10...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers